CD200 Checkpoint Reversal: A Novel Approach to Immunotherapy.

Zhengming XiongElisabet Ampudia MesiasG Elizabeth PluharSusan K RatheDavid A LargaespadaYuk Yin ShamChristopher L MoertelMichael R Olin

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2019)

These results support consideration of a CD200AR-L as a novel platform for immunotherapy against multiple cancers including glioblastoma multiforme.

Keyphrases